Hans Bjornestad
About Hans Bjornestad
Hans Bjornestad is the Executive Director of US Cell Therapy Franchise Marketing and Operations at Bristol Myers Squibb in the Greater Seattle Area.
Title
Hans Bjornestad is the Executive Director of US Cell Therapy Franchise Marketing and Operations at Bristol Myers Squibb.
Current Role at Bristol Myers Squibb
Hans Bjornestad is currently serving as the Executive Director of US Cell Therapy Franchise Marketing and Operations. In addition to this role, he is also the National Senior Director responsible for CAR-T market strategy and operational launch execution. He has been in his current positions since June 2021 and is based in the Greater Seattle Area.
Previous Positions at Juno Therapeutics
Hans worked at Juno Therapeutics, Inc. as the Associate Director of Strategic Marketing - CAR T Cell Therapy from 2017 to 2018. During his tenure, he focused on the strategic marketing aspects of CAR T cell therapy.
Multiple Roles at Bristol Myers Squibb
Hans Bjornestad has a long history with Bristol Myers Squibb, having held various roles over the years. His previous positions include Oncology District Business Manager (2012-2017), Product Manager in Oncology Marketing (2011-2012), Oncology Trainer (2010-2011) in Princeton, New Jersey, and Oncology Sales Specialist in the Northwest (2008-2010). His extensive experience at the company enhances his expertise in oncology marketing and sales.
Education and Background
Hans Bjornestad studied at Washington State University. His educational background and extensive professional experience provide him with the knowledge and skills necessary for his roles in oncology marketing and CAR T market strategy.
Experience in Oncology Marketing and Sales
With over a decade of experience in oncology marketing and sales, Hans Bjornestad has developed a deep understanding of the field. His career has included significant roles involving CAR T market strategy and operational launch execution, contributing to his expertise and leadership in the industry.